Brandon W P, Lee E K
J Health Polit Policy Law. 1984 Spring;9(1):103-24. doi: 10.1215/03616878-9-1-103.
The regulation of HMOs by health planning agencies serves as a "tracer" to aid in evaluating HSAs, and as a source of empirical evidence for the heretofore largely theoretical health policy debate between market reformers and regulators. Two complementary studies (the authors' 1979 survey investigating the hospitalization policies of prepaid group practices, and AMPI 's study of all HMO applications submitted to HSAs from 1975 through mid-1978) provide information about the extent of HMO applications to planning agencies, the rate of rejections, the burden of the planning process of HMOs, and the possibility that negative perceptions of regulation may have led HMOs to refrain from activities requiring planning approval. Both studies reveal that health planning review was detrimental to 20 to 30 percent of HMOs. Thus data collected during the period of extensive HSA regulation of HMOs seem to justify the current policy that gives HSAs only very limited authority over HMOs.
健康规划机构对健康维护组织(HMOs)的监管,可作为评估健康储蓄账户(HSAs)的“追踪器”,并为市场改革者与监管者之间此前大多为理论性的健康政策辩论提供实证依据。两项互补性研究(作者1979年对预付费团体医疗实践的住院政策进行的调查,以及美国医疗保险行业协会(AMPI)对1975年至1978年年中提交给健康储蓄账户的所有健康维护组织申请的研究)提供了有关健康维护组织向规划机构提出申请的范围、被拒率、健康维护组织规划过程的负担,以及对监管的负面看法可能导致健康维护组织避免开展需要规划批准的活动的可能性等信息。两项研究均表明,健康规划审查对20%至30%的健康维护组织不利。因此,在健康储蓄账户对健康维护组织进行广泛监管期间收集的数据,似乎证明了当前赋予健康储蓄账户对健康维护组织的权力非常有限的政策是合理的。